Based on the above, we herein assessed for the first time the expression of Fas and FasL on CTCs and circulating immune cells (PBMCs) in the PB of BC patients to investigate their potential role in the peripheral immune response and prognosis of BC. This evidence concerns the gene FASLG and breast cancer.